Ubs Asset Management Americas Inc Amneal Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 233,895 shares of AMRX stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
233,895
Previous 470,432
50.28%
Holding current value
$2.72 Million
Previous $3.81 Million
38.48%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AMRX
# of Institutions
258Shares Held
150MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA18MShares$209 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...